Infections with the diarrheagenic pathogen, Giardia lamblia, are commonly treated with the 5-nitroimidazole (5-NI) metronidazole (Mz), and yet treatment failures and Mz resistance occur. Using a panel of new 2-ethenyl and 2-ethanyl 5-NI derivatives, we found that compounds with a saturated bridge between the 5-NI core and a pendant ring system exhibited only modestly increased antigiardial activity and could not overcome Mz resistance. By contrast, olefins with a conjugated bridge connecting the core and a substituted phenyl or heterocyclic ring showed greatly increased antigiardial activity without toxicity, and several overcame Mz resistance and were more effective than Mz in a murine giardiasis model. Determination of the half-wave potential of the initial one-electron transfer by cyclic voltammetry revealed that easier redox activation correlated with greater antigiardial activity and capacity to overcome Mz resistance. These studies show the potential of combining systematic synthetic approaches with biological and electrochemical evaluations in developing improved 5-NI drugs.
Infections with the n class="Disease">diarrheagenic pathogen, Giardia lamblia, are commonly treated with the 5-nitroimidazole (5-NI) metronidazole (Mz), and yet treatment failures and Mz resistance occur. Using a panel of new 2-ethenyl and 2-ethanyl 5-NI derivatives, we found that compounds with a saturated bridge between the 5-NI core and a pendant ring system exhibited only modestly increased antigiardial activity and could not overcome Mz resistance. By contrast, olefins with a conjugated bridge connecting the core and a substituted phenyl or heterocyclic ring showed greatly increased antigiardial activity without toxicity, and several overcame Mz resistance and were more effective than Mz in a murinegiardiasis model. Determination of the half-wave potential of the initial one-electron transfer by cyclic voltammetry revealed that easier redox activation correlated with greater antigiardial activity and capacity to overcome Mz resistance. These studies show the potential of combining systematic synthetic approaches with biological and electrochemical evaluations in developing improved 5-NI drugs.
Authors: Hanno Troeger; Hans-Joerg Epple; Thomas Schneider; Ulrich Wahnschaffe; Reiner Ullrich; Gerd-Dieter Burchard; Tomas Jelinek; Martin Zeitz; Michael Fromm; Joerg-Dieter Schulzke Journal: Gut Date: 2006-08-25 Impact factor: 23.059
Authors: M. Aguilar-Martínez; G. Cuevas; M. Jiménez-Estrada; I. González; B. Lotina-Hennsen; N. Macías-Ruvalcaba Journal: J Org Chem Date: 1999-05-14 Impact factor: 4.354
Authors: Linda A Dunn; Anita G Burgess; Kenia G Krauer; Lars Eckmann; Patrice Vanelle; Maxime D Crozet; Frances D Gillin; Peter Upcroft; Jacqueline A Upcroft Journal: Int J Antimicrob Agents Date: 2010-04-24 Impact factor: 5.283
Authors: Janelle M Wright; Linda A Dunn; Zygmunt Kazimierczuk; Anita G Burgess; Kenia G Krauer; Peter Upcroft; Jacqueline A Upcroft Journal: Parasitol Res Date: 2010-06-09 Impact factor: 2.289
Authors: L A Dunn; K S W Tan; P Vanelle; T Juspin; M D Crozet; T Terme; P Upcroft; J A Upcroft Journal: Parasitol Res Date: 2012-02-24 Impact factor: 2.289
Authors: Noa Tejman-Yarden; Yukiko Miyamoto; David Leitsch; Jennifer Santini; Anjan Debnath; Jiri Gut; James H McKerrow; Sharon L Reed; Lars Eckmann Journal: Antimicrob Agents Chemother Date: 2013-02-12 Impact factor: 5.191
Authors: Yukiko Miyamoto; Jaroslaw Kalisiak; Keith Korthals; Tineke Lauwaet; Dae Young Cheung; Ricardo Lozano; Eduardo R Cobo; Peter Upcroft; Jacqueline A Upcroft; Douglas E Berg; Frances D Gillin; Valery V Fokin; K Barry Sharpless; Lars Eckmann Journal: Proc Natl Acad Sci U S A Date: 2013-10-07 Impact factor: 11.205